Literature DB >> 11735375

The expanding spectrum of nuclear gene mutations in mitochondrial disorders.

M Zeviani1.   

Abstract

Our understanding of the molecular basis of mitochondrial disorders has come primarily from the discovery of an expanding number of mutations of mtDNA. However, a variety of recent observations indicate that many syndromes are due to abnormalities in nuclear genes related to oxidative-phosphorylation (OXPHOS). Nuclear genes encode hundreds of proteins involved in mitochondrial OXPHOS. Nevertheless, the identification of these genes has proceeded at a much slower pace, compared with the discovery and characterization of mtDNA mutations. This scenario is rapidly changing, thanks to the discovery of several OXPHOS-related human genes, and to the identification of mutations responsible for different clinical syndromes. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11735375     DOI: 10.1006/scdb.2001.0278

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  5 in total

1.  Past, present and future therapeutics for cerebellar ataxias.

Authors:  D Marmolino; M Manto
Journal:  Curr Neuropharmacol       Date:  2010-03       Impact factor: 7.363

2.  FASTKD2 nonsense mutation in an infantile mitochondrial encephalomyopathy associated with cytochrome c oxidase deficiency.

Authors:  Daniele Ghezzi; Ann Saada; Pio D'Adamo; Erika Fernandez-Vizarra; Paolo Gasparini; Valeria Tiranti; Orly Elpeleg; Massimo Zeviani
Journal:  Am J Hum Genet       Date:  2008-09-04       Impact factor: 11.025

Review 3.  Cardiological manifestations of mitochondrial respiratory chain disorders.

Authors:  A Berardo; O Musumeci; A Toscano
Journal:  Acta Myol       Date:  2011-06

4.  Global kinome profiling reveals DYRK1A as critical activator of the human mitochondrial import machinery.

Authors:  Corvin Walter; Adinarayana Marada; Tamara Suhm; Ralf Ernsberger; Vera Muders; Cansu Kücükköse; Pablo Sánchez-Martín; Zehan Hu; Abhishek Aich; Stefan Loroch; Fiorella Andrea Solari; Daniel Poveda-Huertes; Alexandra Schwierzok; Henrike Pommerening; Stanka Matic; Jan Brix; Albert Sickmann; Claudine Kraft; Jörn Dengjel; Sven Dennerlein; Tilman Brummer; F-Nora Vögtle; Chris Meisinger
Journal:  Nat Commun       Date:  2021-07-13       Impact factor: 14.919

Review 5.  Clinical Diagnosis and Treatment of Leigh Syndrome Based on SURF1: Genotype and Phenotype.

Authors:  Inn-Chi Lee; Kuo-Liang Chiang
Journal:  Antioxidants (Basel)       Date:  2021-12-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.